Cellectar Biosciences Cash from Financing (TTM) Insights

Cellectar Biosciences Inc (CLRB)

3.02 -0.04 (-1.31%) USD | NASDAQ | Apr 25, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2005. Upgrade now.

Date	Value
December 31, 2023	22.94M
September 30, 2023	32.11M
June 30, 2023	9.611M
March 31, 2023	9.611M
December 31, 2022	9.611M
September 30, 2022	0.00
June 30, 2022	0.00
March 31, 2022	0.0349M
December 31, 2021	1.249M
September 30, 2021	43.46M
June 30, 2021	43.35M
March 31, 2021	61.76M
December 31, 2020	60.55M
September 30, 2020	18.34M
June 30, 2020	18.44M
March 31, 2020	9.023M
December 31, 2019	9.022M
September 30, 2019	9.022M
June 30, 2019	24.14M
March 31, 2019	15.02M
December 31, 2018	15.02M
September 30, 2018	22.19M
June 30, 2018	6.994M
March 31, 2018	7.081M
December 31, 2017	9.929M

Date	Value
September 30, 2017	10.97M
June 30, 2017	10.99M
March 31, 2017	18.92M
December 31, 2016	15.94M
September 30, 2016	10.63M
June 30, 2016	10.50M
March 31, 2016	2.577M
December 31, 2015	2.707M
September 30, 2015	-0.1917M
June 30, 2015	12.05M
March 31, 2015	11.87M
December 31, 2014	15.87M
September 30, 2014	15.87M
June 30, 2014	3.824M
March 31, 2014	3.998M
December 31, 2013	5.043M
September 30, 2013	7.878M
June 30, 2013	8.029M
March 31, 2013	12.90M
December 31, 2012	7.854M
September 30, 2012	10.48M
June 30, 2012	10.22M
March 31, 2012	9.565M
December 31, 2011	9.515M
September 30, 2011	4.459M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Jun 2022

61.76M

Maximum

Mar 2021

20.12M

Average

9.611M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks